AstraZeneca AB v. Mylan Pharmaceuticals Inc.
| ASTRAZENECA AB and ASTRAZENECA PHARMACEUTICALS LP |
| MYLAN PHARMACEUTICALS INC. and KINDEVA DRUG DELIVERY L.P. |
| 23-1164 |
| November 18, 2022 |
| U.S. Court of Appeals, Federal Circuit |
| Patent Infringement (Fed. Qst.) |
Opinions
We have the following opinions for this case:
| Description |
|---|
| ASTRAZENECA AB v. MYLAN PHARMACEUTICALS INC. |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 13, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 43
ORDER filed denying Mylan's Rule 8 motion [ # 891884-2 ]. The temporary stay entered on December 21, 2022, is lifted.; granting motion to expedite [ # 891888-2 ] to the following extent: (a) in Appeal No. 2023-1267, AstraZeneca's response brief is due no later than February 9, 2023; Mylan's reply brief is due no later than February 16, 2023; the joint appendix is due no later than February 17, 2023; and (b) Appeal Nos. 2023-1164 and 2023-1267 shall be considered companion cases and set for argument before the same panel on March 8, 2023, at 10:00 AM, superseding the notice of oral argument for Appeal No. 2023-1164 issued on December 9, 2022. (Per Curiam). Service as of this date by the Clerk of Court. [896981] [23-1267, 23-1164] [LMS] [Entered: 01/13/2023 03:34 PM]
|
| Filing 41 MODIFIED ENTRY: REPLY BRIEF FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/12/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [896617] --[Edited 01/13/2023 by ALK - compliance review complete] [David Berl] [Entered: 01/12/2023 01:27 PM] |
| Filing 42 6 paper copies of Doc. No. [ # 37 ] received from Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc.. [896653] [VDW] [Entered: 01/12/2023 03:03 PM] |
| Filing 40 6 paper copies of Doc. No. [15] received from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. [896415] [VDW] [Entered: 01/11/2023 04:16 PM] |
| Filing 39 Corrected Response to notice of oral argument from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 01/05/2023 by email. [894847] [23-1164] [David Berl] [Entered: 01/05/2023 12:04 PM] |
| Filing 38 CLERK'S OFFICE QUALITY CONTROL MESSAGE: Appellants' response to notice of oral argument (RNOA) [ # 34 ] indicates that counsel intends to argue for a total of 20 minutes. Main argument time and rebuttal time together must not exceed 15 minutes. CORRECTION: No later than 01/12/2023, please file a corrected RNOA that identifies a time division that does not exceed 15 total minutes. [894802] [MJL] [Entered: 01/05/2023 11:07 AM] |
| Filing 37 MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc. Service: 01/03/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [894324] --[Edited 01/05/2023 by ALK - compliance review complete] [Nathan Kelley] [Entered: 01/03/2023 08:01 PM] |
| Filing 36 Amended Certificate of Interest for Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 01/03/2023 by email. [894221] [23-1164] [Nathan Kelley] [Entered: 01/03/2023 02:39 PM] |
| Filing 35 Response to notice of oral argument from Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 12/30/2022 by clerk. [894000] [23-1164] [Andrew Dufresne] [Entered: 12/30/2022 06:01 PM] |
| Filing 34 Response to notice of oral argument from Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 12/30/2022 by email. [893986] [23-1164] [David Berl] [Entered: 12/30/2022 04:37 PM] |
| Filing 33 Entry of appearance for Matthew Greinert as counsel for Appellee Mylan Pharmaceuticals Inc. Service: 12/23/2022 by clerk. [892829] [MVH] [Entered: 12/23/2022 04:51 PM] |
| Filing 32 Entry of appearance for Dan L. Bagatell as counsel for Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc. Service: 12/23/2022 by. [892827] [MVH] [Entered: 12/23/2022 04:50 PM] |
| Filing 31 Entry of appearance for Kevin Hoagland-Hanson as counsel for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 12/23/2022 by clerk. [892825] [MVH] [Entered: 12/23/2022 04:49 PM] |
|
Filing 30
ORDER filed granting motions for leave to appear as counsel filed by Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.l [ # 29 ] and filed by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP [ # 28 ]. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [892823] [MVH] [Entered: 12/23/2022 04:48 PM]
|
| Filing 29 MOTION of Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. for leave to file entry of appearance for Dan L. Bagatell; Matthew Greinert. Service: 12/22/2022 by email. [892577] [23-1164] [Nathan Kelley] [Entered: 12/22/2022 06:16 PM] |
| Filing 28 MOTION of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP for leave to file entry of appearance for Kevin Hoagland-Hanson. Service: 12/22/2022 by email. [892570] [23-1164] [David Berl] [Entered: 12/22/2022 05:52 PM] |
| Filing 27 NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Entry of Appearance [ # 26 ], is not in compliance with the rules of this court (see attached). Compliant document due on 12/30/2022. Service as of this date by the Clerk of Court. [892500] [CMH] [Entered: 12/22/2022 02:17 PM] |
| Filing 26 Entry of appearance for Kevin Hoagland-Hanson as counsel for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 12/13/2022 by email. [890467] [23-1164] This document is non-compliant. See Doc No. [ # 27 ]. [David Berl] [Entered: 12/13/2022 04:20 PM] |
| Filing 25 NOTICE OF NON-COMPLIANCE: The submissions of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Opening Brief and Confidential Opening Brief, [15] and [ # 16 ], are not in compliance with the rules of this court (see attached). Compliant documents due on 12/20/2022. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [890410] [ALK] [Entered: 12/13/2022 02:36 PM] |
| Filing 24 NOTICE OF ORAL ARGUMENT. Panel: 2302B. Case scheduled February 10, 2023. Response to Notice of Oral Argument due: 12/30/2022. Please review the attached Notice. The response to notice of oral argument form can be found # here . The Oral Argument Guide can be found # here . Service as of this date by the Clerk of Court. [889705] [MJL] [Entered: 12/09/2022 03:04 PM] |
|
Filing 23
ORDER filed denying [ # 10 ] [ # 13 ] the motion to expedite filed by AstraZeneca AB and AstraZeneca Pharmaceuticals LP. (Per Curiam). Service as of this date by the Clerk of Court. [889049] [LMS] [Entered: 12/07/2022 11:51 AM]
|
| Filing 22 Entry of appearance for Andrew T. Dufresne as counsel for Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 12/06/2022 by clerk. [888730] [23-1164] [Andrew Dufresne] [Entered: 12/06/2022 02:38 PM] |
| Filing 21 REPLY of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to response [ # 19 ]. Service: 12/02/2022 by email. [887968] [23-1164] [David Berl] [Entered: 12/02/2022 03:15 PM] |
| Filing 20 Docketing Statement for the Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 12/02/2022 by email. [887967] [23-1164] [Nathan Kelley] [Entered: 12/02/2022 03:13 PM] |
| Filing 19 RESPONSE of Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. to Doc No. [ # 13 ], [ # 13 ]. Service: 11/29/2022 by email. [887072] [23-1164] [Nathan Kelley] [Entered: 11/29/2022 08:51 PM] |
| Filing 18 Certificate of Interest for Appellees Kindeva Drug Delivery L.P. and Mylan Pharmaceuticals Inc.. Service: 11/28/2022 by email. [886811] [23-1164] [Nathan Kelley] [Entered: 11/28/2022 06:20 PM] |
| Filing 17 Corrected Certificate of Service filed by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to Doc No. [15]. Service: 11/28/2022 by email. [886810] [23-1164] [David Berl] [Entered: 11/28/2022 06:12 PM] |
| Filing 16 MODIFIED ENTRY: OPENING BRIEF FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/23/2022 by email. [886509] --[Edited 01/05/2023 by ALK - compliance review complete] [David Berl] [Entered: 11/23/2022 08:17 PM] |
| Filing 15 MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED by Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/23/2022 by email. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [886508]--[Edited 01/05/2023 by ALK - compliance review complete] [David Berl] [Entered: 11/23/2022 08:14 PM] |
|
Filing 14
ORDER Any opposition to the motion [ # 13 ] is due no later than seven days from the date of filing of this order. Any reply is due no later than three days thereafter. AstraZeneca's opening brief is due no later than 11/23/2022. Service as of this date by the Clerk of Court. [886159] [NL] [Entered: 11/22/2022 02:45 PM]
|
| Filing 13 MOTION of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to expedite briefing schedule, to expedite hearing. Service: 11/21/2022 by email. [885477] [23-1164] [David Berl] [Entered: 11/21/2022 01:28 PM] |
| Filing 12 Notice of Correction to Doc No. [ # 10 ], [ # 10 ] for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/21/2022 by email. [885475] [23-1164] [David Berl] [Entered: 11/21/2022 01:26 PM] |
| Filing 11 Docketing Statement for the Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/21/2022 by email. [885315] [23-1164] [David Berl] [Entered: 11/21/2022 10:49 AM] |
| Filing 10 MOTION of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to expedite briefing schedule, to expedite hearing. Service: 11/21/2022 by email. [885312] [23-1164] [David Berl] [Entered: 11/21/2022 10:47 AM] |
| Filing 9 Amended Certificate of Interest for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/21/2022 by email. [885300] [23-1164] [David Berl] [Entered: 11/21/2022 10:33 AM] |
| Filing 8 Amended Entry of appearance for David I. Berl; David M. Krinsky; Anthony Sheh; Jessica P. Ryen; Arthur J. Argall III; Christopher N. Sipes; Tarek Austin; Gary M. Rubman; Douglas A. Behrens; Matthew Kudzin as counsel for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/21/2022 by email. [885297] [23-1164] [David Berl] [Entered: 11/21/2022 10:30 AM] |
| Filing 7 NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Motion to Expedite [ # 3 ], is not in compliance with the rules of this court (see attached). Compliant document due on 11/30/2022. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [885260] [ALK] [Entered: 11/21/2022 09:35 AM] |
| Filing 6 NOTICE OF NON-COMPLIANCE: The submission of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP, Entry of Appearance [ # 2 ], is not in compliance with the rules of this court (see attached). Compliant document due on 11/30/2022. Service as of this date by the Clerk of Court. [885250] [ALK] [Entered: 11/21/2022 09:16 AM] |
| Filing 5 Entry of appearance for Shannon M. Bloodworth; David L. Anstaett; Nathan K. Kelley; Emily J. Greb; Brandon M. Lewis as counsel for Appellees Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.. Service: 11/21/2022 by email. [885239] [23-1164] [Nathan Kelley] [Entered: 11/21/2022 08:37 AM] |
| Filing 4 Certificate of Interest for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/18/2022 by email. [885217] [23-1164] [David Berl] [Entered: 11/18/2022 05:49 PM] |
| Filing 3 MOTION of Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP to expedite briefing schedule, to expedite hearing. Service: 11/18/2022 by email. [885150] [23-1164] This document is non-compliant. See Doc No. [ # 7 ]. [David Berl] [Entered: 11/18/2022 04:04 PM] |
| Filing 2 Entry of appearance for David I. Berl; David M. Krinsky; Anthony Sheh; Jessica P. Ryen; Kevin D. Hoagland-Hanson; Arthur J. Argall III; Christopher N. Sipes; Gary M. Rubman; Douglas A. Behrens; Matthew Kudzin; Tarek Austin as counsel for Appellants AstraZeneca AB and AstraZeneca Pharmaceuticals LP. Service: 11/18/2022 by email. [885139] [23-1164] This document is non-compliant. See Doc No. [ # 6 ]. [David Berl] [Entered: 11/18/2022 03:54 PM] |
| Filing 1 Appeal docketed. Received: 11/11/2022. [885032] Entry of Appearance is due on 12/02/2022. Certificate of Interest is due on 12/02/2022. Docketing Statement is due on 12/02/2022. Appellants' brief is due on 01/17/2023. [ALK] [Entered: 11/18/2022 01:56 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
